SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.51+2.7%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (6750)7/17/2002 2:14:47 PM
From: David Howe  Read Replies (1) of 52153
 
<< He also makes a big fuss about relative P/S ratios only to concede a little later that you can't compare these across industries. >>

Very annoying article. He compares the P/S ratio of the high margin pharma business with low margin businesses like Walmart and then declares that based on P/S the pharmas are a SELL. The people that stop reading at that point will have been mislead.

Then, later in the article he declares his original comparisons completely invalid.

No wonder the general public is so confused about valuations.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News